Target intelligence / Profile preview

Ribosomal protein S2 pseudogene 25 (RPS2P25)

Target
RPS2P25
Molecular classification
Other (pseudogene)
01

Overview

RPS2P25 is a processed pseudogene derived from the ribosomal protein S2 (RPS2) gene. Pseudogenes are DNA sequences that resemble functional genes but generally lack the ability to encode functional proteins due to disabling mutations, truncations, or lack of regulatory elements[9][6][8]. Pseudogenes such as RPS2P25 serve as remnants of gene duplication or retrotransposition events and are largely considered nonfunctional in protein coding. While most pseudogenes do not have biological activity, a minority may be transcribed and exert regulatory roles (such as acting as microRNA sponges or influencing gene expression), but there is no evidence that RPS2P25 has functional activity or disease association in current biomedical literature[7][9]. RPS2P25 represents a nonfunctional pseudogene and should not be confused with the functional ribosomal protein S2 (RPS2). It is not a conventional therapeutic target, receptor, or enzyme and has no known drug interactions or clinical biomarker relevance. If your interest is in ribosomal protein S2 itself, reference the RPS2 gene rather than the pseudogene RPS2P25[4][6][9].

Other names
ribosomal protein S2 pseudogene 25RPS2P25processed pseudogene of ribosomal protein S2
02

Biological functions

Other (no direct biological function; represents a nonfunctional genomic element derived from the RPS2 gene, though some pseudogenes may rarely be transcribed or play regulatory roles[9][7])
03

Disease associations

Other (not directly implicated in disease; functional disruptions would more commonly involve the parental RPS2 gene, not its pseudogenes[4])

Beyond the preview

Go deeper on Ribosomal protein S2 pseudogene 25 (RPS2P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S2 pseudogene 25 (RPS2P25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call